Copyright
©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 112882
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112882
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112882
Table 1 Contingency table
| Alternative criteria | 100-g OGTT | ||
| Positive | Negative | Total | |
| Positive | 20 | 24 | 44 |
| Negative | 60 | 250 | 310 |
| Total | 80 | 274 | 354 |
Table 2 Comparison between study groups regarding clinical characteristics and obstetric and perinatal outcomes
| Parameter | OGTT+/A+ (n = 20) | OGTT+/A- (n = 54) | OGTT-/A+ (n = 21) | OGTT-/A- (n = 234) | P value |
| Age (years) | 33.1 ± 4.2 | 33.7 ± 5.5 | 33.7 ± 5.1 | 33.8 ± 5.1 | 0.959 |
| Pregestational BMI (kg/m2) | 30.1 ± 6.3c | 26.8 ± 5.1b | 32.7 ± 5.3a,c | 25.6 ± 5.0b,d | < 0.001 |
| Pregestational obesity prevalence (%) | 40.0 | 28.3 | 70.8 | 18.0 | < 0.001 |
| Pregnancy weight gain (kg) | 5.5 ± 5.8 | 6.4 ± 5.6 | 5.2 ± 6.5 | 6.3 ± 4.3 | 0.666 |
| Past pregnancies (%) | 80.0 | 57.6 | 58.3 | 59.6 | 0.320 |
| Previous abortions (%) | 30.0 | 37.3 | 37.5 | 37.8 | 0.924 |
| Family history on DM (%) | 30.0 | 36.7 | 37.5 | 39.6 | 0.842 |
| Personal history GDM (%) | 36.8 | 25.0 | 22.2 | 15.2 | 0.088 |
| Previous macrosomic newborns (%) | 21.1 | 0 | 16.7 | 7.3 | 0.016 |
| Risk of GDM (%) | 22.5 ± 23.4a | 14.6 ± 18.4b | 16.7 ± 14.6a,b | 10.1 ± 12.4c | < 0.001 |
| O’Sullivan test (mg/dL) | 183.3 ± 32.1a,b,c | 168.3 ± 21.1c,d | 165.9 ± 29.8d | 156.9 ± 14.7a,d | < 0.001 |
| Gestational age at 100-g OGTT (weeks) | 25.9 ± 4.9 | 26.3 ± 3.7 | 25.0 ± 6.2 | 25.5 ± 4.6 | 0.541 |
| FPG (mg/dL) | 106.3 ± 14.4a,b,c | 83.5 ± 6.4b,d | 94.3 ± 6.7a,c,d | 81.3 ± 5.7b,d | < 0.001 |
| 60 minutes glucose (mg/dL) | 206.6 ± 39.5b,c | 193.8 ± 26.1b,c | 166.2 ± 25.2a,d | 154.4 ± 26.8a,d | < 0.001 |
| 120 minutes glucose (mg/dL) | 186.7 ± 28.2b,c | 179.1 ± 20.5b,c | 146.7 ± 20.0a,c,d | 129.3 ± 24.4a,b,d | < 0.001 |
| 180 minutes glucose (mg/dL) | 142.3 ± 27.9b,c | 139.5 ± 32.8b,c | 113.6 ± 24.2a,d | 105.4 ± 27.1a,d | < 0.001 |
| HbA1c (%) | 5.6 ± 0.4a,c | 5.1 ± 0.2b,c,d | 5.5 ± 0.3a,c | 5.0 ± 0.2a,b,d | < 0.001 |
| Gestational age at delivery (weeks) | 38.8 ± 1.2 | 38.8 ± 1.2 | 38.7 ± 1.9 | 38.9 ± 1.7 | 0.957 |
| Preterm birth (%) | 5.0 | 3.7 | 4.8 | 6.0 | 0.925 |
| Birthweight (g) | 3326.7 ± 528.2a,c | 3157.8 ± 397.9d | 3505.8 ± 592.0 | 3221.7 ± 493.9d | 0.001 |
| Birthweight percentile | 72.6 ± 27.3a,c | 46.8 ± 28.2b,d | 72.3 ± 23.7a | 52.9 ± 28.8d | < 0.001 |
| SGA/LGA (%) | 5.0/35.0 | 9.2/11.1 | 0/28.6 | 6.4/13.7 | 0.028 |
| Birth length (cm) | 51.2 ± 2.0a | 49.2 ± 3.3d | 50.6 ± 2.4 | 50.0 ± 2.4 | 0.033 |
| Head circumference (cm) | 34.4 ± 1.5 | 33.5 ± 1.5 | 34.0 ± 1.9 | 33.5 ± 1.6 | 0.175 |
| Sex of newborn | 0.837 | ||||
| Female (%) | 50.0 | 51.0 | 41.2 | 45.0 | |
| Male (%) | 50.0 | 49.0 | 58.8 | 55.0 | |
| Induction of labor (%) | 30.0 | 27.7 | 33.3 | 22.6 | 0.789 |
| Type of delivery | 0.223 | ||||
| Noninstrumental vaginal (%) | 31.6 | 66.0 | 52.9 | 52.6 | |
| Instrumental (%) | 10.5 | 8.0 | 11.8 | 13.1 | |
| Cesarean (%) | 57.9 | 26.0 | 35.3 | 34.3 | |
| Any perinatal complication (%) | 25.0 | 17.3 | 14.3 | 13.2 | 0.503 |
Table 3 Univariate and multivariate logistic regression analysis for large for gestational age newborns
| Independent variables | Univariate | Multivariate | ||||
| OR | 95%CI | P value | OR | 95%CI | P value | |
| Age (years) | 0.995 | 0.938-1.056 | 0.877 | |||
| Gestational age at test (weeks) | 1.044 | 0.971-1.123 | 0.245 | |||
| Parity | ||||||
| Primigravida | 1 (reference) | |||||
| Multigravida | 1.860 | 0.956-3.610 | 0.066 | |||
| OGTT status | 0.631 | |||||
| OGTT negative | 1 (reference) | |||||
| OGTT positive | 1.183 | 0.592-2.374 | ||||
| A criteria status | 0.001 | |||||
| A negative | 1 (reference) | |||||
| A positive | 4.291 | 1.814-10.153 | ||||
| Pregestational BMI (kg/m2) | 1.071 | 1.016-1.128 | 0.010 | 1.069 | 1.002-1.140 | 0.042 |
| Pregnancy weight gain (kg) | 1.068 | 1.002-1.138 | 0.042 | |||
| Personal history of GDM | 0.224 | |||||
| No | 1 (reference) | |||||
| Yes | 1.826 | 0.692-4.819 | ||||
| Previous macrosomic newborns | 0.001 | |||||
| No | 1 (reference) | 1 (reference) | ||||
| Yes | 6.897 | 2.183-21.788 | 7.948 | 2.269-27.842 | 0.001 | |
| FPG (mg/dL) | 1.065 | 1.025-1.108 | 0.001 | |||
| HbA1c (%) | 1.745 | 0.654-4.653 | 0.266 | |||
| Treatment for GDM | 0.521 | |||||
| Diet | 1 (reference) | |||||
| Insulin | 1.507 | 0.431-5.273 | ||||
- Citation: Molina-Vega M, Estébanez-Prieto MJ, Fernández-Valero A, Lima-Rubio F, Fernández-Ramos AM, Linares-Pineda TM, Morcillo S, Picón-César MJ. Role of fasting glucose and glycated hemoglobin for gestational diabetes mellitus diagnosis: A prospective study. World J Diabetes 2026; 17(1): 112882
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/112882.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.112882
